Core Viewpoint - The announcement from Baicheng Pharmaceutical indicates that four shareholders plan to reduce their holdings due to personal financial needs, which may impact the company's stock performance in the short term [1] Shareholder Reduction Plans - Shareholder Jia Fei intends to reduce his holdings by no more than 12,200 shares, representing 0.0112% of the company's total share capital [1] - Shareholder Song Bofan plans to reduce his holdings by no more than 2,300 shares, which accounts for 0.0021% of the total share capital [1] - Shareholder Yan Hongbing aims to reduce his holdings by no more than 9,500 shares, equivalent to 0.0088% of the total share capital [1] - Shareholder Chen An is set to reduce his holdings by no more than 11,200 shares, making up 0.0103% of the total share capital [1] Implementation Timeline - The reduction plans will be executed within three months starting from 15 trading days after the announcement date, with specific timing and pricing remaining uncertain [1]
百诚医药：多位股东计划减持股份